Business Description
SK Bioscience Co Ltd
ISIN : KR7302440003
Compare
Compare
Traded in other countries / regions
302440.Korea IPO Date
2021-03-18Description
SK Bioscience Co Ltd is a South Korean pharmaceutical company. It is engaged in the manufacturing and developing of vaccine. The company has registered SKYCellflu prefilled syringe (PFS), the first cell culture influenza vaccine in Korea, followed by the licensure of SKYCellflu Quadrivalent prefilled syringe and 13-valent Pneumococcal Conjugate Vaccine. Further it has several other vaccines under development and clinical trials including recombinant rotavirus vaccine. In addition, the development of new typhoid conjugate vaccine and innovative pneumococcal vaccine is ongoing in collaboration with external partners.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 6.53 | |||||
| Equity-to-Asset | 0.84 | |||||
| Debt-to-Equity | 0.12 | |||||
| Debt-to-EBITDA | -7.87 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | 8.21 | |||||
| Beneish M-Score | -2.65 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 9.5 | |||||
| 3-Year EBITDA Growth Rate | -15.6 | |||||
| 3-Year EPS without NRI Growth Rate | -11.4 | |||||
| 3-Year Book Growth Rate | 72.6 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 34.83 | |||||
| 9-Day RSI | 43.92 | |||||
| 14-Day RSI | 46.94 | |||||
| 6-1 Month Momentum % | -2.55 | |||||
| 12-1 Month Momentum % | -31.05 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 11.69 | |||||
| Quick Ratio | 10.86 | |||||
| Cash Ratio | 10.43 | |||||
| Days Inventory | 277.77 | |||||
| Days Sales Outstanding | 49.71 | |||||
| Days Payable | 23.19 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -7.9 | |||||
| Shareholder Yield % | -1.26 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 27.2 | |||||
| Operating Margin % | -47.73 | |||||
| Net Margin % | -21.5 | |||||
| FCF Margin % | -94.99 | |||||
| ROE % | -2.52 | |||||
| ROA % | -2.23 | |||||
| ROIC % | -9.91 | |||||
| ROC (Joel Greenblatt) % | -16.67 | |||||
| ROCE % | -3.49 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 19.24 | |||||
| PB Ratio | 2.25 | |||||
| Price-to-Tangible-Book | 2.29 | |||||
| EV-to-EBIT | -43.48 | |||||
| EV-to-Forward-EBIT | 42.62 | |||||
| EV-to-EBITDA | -104.68 | |||||
| EV-to-Forward-EBITDA | 36.21 | |||||
| EV-to-Revenue | 13.56 | |||||
| EV-to-Forward-Revenue | 10.41 | |||||
| EV-to-FCF | -14.27 | |||||
| Price-to-Net-Current-Asset-Value | 3.29 | |||||
| Price-to-Net-Cash | 3.82 | |||||
| Earnings Yield (Greenblatt) % | -2.3 | |||||
| FCF Yield % | -4.95 | |||||
| Forward Rate of Return (Yacktman) % | -39.66 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
SK Bioscience Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 201,300.041 | ||
| EPS (TTM) (â‚©) | -563 | ||
| Beta | 1.35 | ||
| Volatility % | 22.26 | ||
| 14-Day RSI | 46.94 | ||
| 14-Day ATR (â‚©) | 2862.071846 | ||
| 20-Day SMA (â‚©) | 51435 | ||
| 12-1 Month Momentum % | -31.05 | ||
| 52-Week Range (â‚©) | 43650 - 73700 | ||
| Shares Outstanding (Mil) | 76.83 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
SK Bioscience Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
SK Bioscience Co Ltd Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
SK Bioscience Co Ltd Frequently Asked Questions
What is SK Bioscience Co Ltd(XKRX:302440)'s stock price today?
The current price of XKRX:302440 is â‚©50300.00. The 52 week high of XKRX:302440 is â‚©73700.00 and 52 week low is â‚©43650.00.
When is next earnings date of SK Bioscience Co Ltd(XKRX:302440)?
The next earnings date of SK Bioscience Co Ltd(XKRX:302440) is .
Does SK Bioscience Co Ltd(XKRX:302440) pay dividends? If so, how much?
SK Bioscience Co Ltd(XKRX:302440) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers